Prime Medicine, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 856K | 838K | 1.2M | 1.1M | 1.5M | 2.2M | 209K | 0 |
| Cost of Goods Sold | 1.9M | 0 | 44.0M | 1.9M | 0 | 0 | 0 | 0 |
| Gross Profit | -1.0M | 838K | -42.8M | -749K | 1.5M | 2.2M | 209K | 0 |
| R&D Expenses | 34.1M | 34.7M | 44.0M | 41.4M | 40.6M | 34.1M | 40.3M | 43.1M |
| Operating Expenses | 49.7M | 49.4M | 11.2M | 52.6M | 53.8M | 46.4M | 54.4M | 55.7M |
| Operating Income | -50.7M | -48.6M | -54.0M | -53.4M | -52.4M | -44.2M | -54.2M | -55.7M |
| Other Income / Gains | 1.5M | 2.5M | 3.4M | 786K | 502K | 1.9M | 1.7M | 211K |
| Net Income | -49.1M | -46.1M | -50.6M | -52.6M | -51.9M | -42.3M | -52.5M | -55.3M |
| EPS (Diluted) | -0.28 | -0.26 | -0.32 | -0.407 | -0.397 | -0.357 | -0.439 | -0.464 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | -1.168 | 1.00 | -34.91 | -0.672 | 1.00 | 1.00 | 1.00 | 0 |
| General And Administrative Expenses | 17.4M | 14.7M | 11.2M | 13.1M | 13.3M | 12.3M | 14.1M | 12.6M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 17.4M | 14.7M | 11.2M | 13.1M | 13.3M | 12.3M | 14.1M | 12.6M |
| Other Expenses | -1.9M | 0 | -44.0M | -1.9M | 0 | 0 | 0 | 0 |
| Cost And Expenses | 51.5M | 49.4M | 55.2M | 54.5M | 53.8M | 46.4M | 54.4M | 55.7M |
| Interest Income | 1.5M | 1.1M | 1.1M | 1.3M | 1.2M | 1.5M | 697K | 611K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 1.9M | 1.9M | 1.9M | 1.9M | 1.7M | 1.7M | 1.6M | 1.5M |
| Ebitda | -48.8M | -46.7M | -48.7M | -51.5M | -50.7M | -42.5M | -52.7M | -54.1M |
| Ebitdaratio | -57.007 | -55.766 | -39.756 | -46.20 | -34.864 | -19.471 | -252.029 | 0 |
| Operating Income Ratio | -59.175 | -58.005 | -44.06 | -47.872 | -36.033 | -20.257 | -259.483 | 0 |
| Income Before Tax | -49.1M | -46.1M | -50.6M | -52.6M | -51.9M | -42.3M | -52.5M | -55.5M |
| Income Before Tax Ratio | -57.386 | -54.987 | -41.291 | -47.167 | -35.688 | -19.366 | -251.282 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -134K |
| Net Income Ratio | -57.386 | -54.987 | -41.291 | -47.167 | -35.688 | -19.366 | -251.282 | 0 |
| Epsdiluted | -0.28 | -0.26 | -0.32 | -0.407 | -0.397 | -0.357 | -0.439 | -0.464 |
| Weighted Average Shs Out | 177.1M | 148.8M | 160.5M | 129.2M | 130.9M | 118.6M | 119.8M | 119.2M |
| Weighted Average Shs Out Dil | 177.1M | 148.8M | 160.5M | 129.2M | 130.9M | 118.6M | 119.8M | 119.2M |